12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga·02/26/2026 21:05:56
Listen to the news
Gainers
- Kairos Pharma (AMEX:KAPA) stock rose 11.3% to $0.61 during Thursday's after-market session. The market value of their outstanding shares is at $13.0 million.
- Neurogene (NASDAQ:NGNE) shares increased by 6.7% to $21.0. The market value of their outstanding shares is at $311.1 million.
- PharmaCyte Biotech (NASDAQ:PMCB) shares moved upwards by 6.53% to $0.75. The company's market cap stands at $7.3 million.
- Curanex Pharmaceuticals (NASDAQ:CURX) stock moved upwards by 6.32% to $0.49. The market value of their outstanding shares is at $8.9 million.
- Cue Biopharma (NASDAQ:CUE) shares rose 4.16% to $0.3. The company's market cap stands at $25.8 million.
- bioAffinity Technologies (NASDAQ:BIAF) stock rose 3.84% to $1.08. The market value of their outstanding shares is at $4.9 million.
Losers
- BioLine Rx (NASDAQ:BLRX) shares decreased by 11.0% to $2.56 during Thursday's after-market session. The market value of their outstanding shares is at $10.2 million.
- Cypherpunk Technologies (NASDAQ:CYPH) shares declined by 9.15% to $0.63. The market value of their outstanding shares is at $38.8 million.
- VSee Health (NASDAQ:VSEE) shares decreased by 7.14% to $0.35. The market value of their outstanding shares is at $13.9 million.
- Vivos Therapeutics (NASDAQ:VVOS) shares fell 6.21% to $1.36. The market value of their outstanding shares is at $16.7 million.
- Dentsply Sirona (NASDAQ:XRAY) shares declined by 5.98% to $11.95. The company's market cap stands at $2.5 billion. As per the press release, Q4 earnings came out today.
- Progyny (NASDAQ:PGNY) shares declined by 5.62% to $21.0. The market value of their outstanding shares is at $1.8 billion. The company's, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.